Loading…
Login
Scholar Register
Business Register
Subscribe
Loading…
Article Title
Abstract
Keyword
Category
MESH Heading
Grant Agency
RCAID
DOI
PMID
PMCID
Author
Affiliation
Email
Journal Title
ISSN
Publisher
Loading…
Contains
Equals
Find an Article
Find an Author
Find an Article (54959121)
Find a Category (126)
Find a Journal (6153)
Find a Scholar (4058)
Find an Academic Assistant (17)
Find an Article PDF (4587050)
Today's Articles (5)
Subscriber (49257)
Download
Citation(s) in
RCA
1
(from Reference Citation Analysis)
Indexed Articles
Today (0)
Yesterday (0)
This Week (0)
Last Week (0)
Current Month (0)
Last Month (0)
Ranked By
Impact Index Per Article
Citation(s) in
RCA
Results Analysis
Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis
Results Analysis
Year Published
2024 (1)
Show more
Refine
Article Type
(1)
Show more
Refine
Article Statistics
Refine
MESH Headings
Show more
Refine
First Author
Peter Mu-Hsin Chang (1)
Show more
Refine
Authors
Peter Mu-Hsin Chang (1)
Show more
Refine
Publication Titles
THE LANCET. HEALTHY LONGEVITY (1)
Show more
Refine
Grant Agencies
Show more
Refine
Countries/Regions
Taiwan (1)
Show more
Refine
Affiliations
NATIONAL YANG MING CHIAO TUNG UNIVERSITY (1)
Show more
Refine
Category
Show more
Refine
For:
Guigay J
, Ortholan C, Vansteene D, Cupissol D, Even C, Kaminsky MC, Sire C, Blot E, Debourdeau P, Bozec L, Saada-Bouzid E, Fayette J, Dalloz P, Pointreau Y, Caer HL, Falandry C, Digue L, Braccini A, Lopez S, Guillet P, Michel C, Cheurfa N, Schwob D, Bourhis J, Mertens C, Aupérin A.
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Lancet Healthy Longev
2024;
5
:e182-e193. [PMID:
38432247
DOI:
10.1016/s2666-7568(23)00284-2
]
[
Citation(s) in
RCA
: 1
]
[
Impact Index Per Article: 1.0
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Received: 09/01/2023]
[Revised: 12/20/2023]
[Accepted: 12/21/2023]
[Indexed: 03/05/2024]
Open
Number
Cited by Other Article(s)
1
Chang PMH
.
Is systemic anticancer treatment suitable for older patients?
Lancet Healthy Longev
2024;
5
:e166-e167. [PMID:
38432245
DOI:
10.1016/s2666-7568(24)00023-0
]
[
Citation(s) in
RCA
: 0
]
[
Impact Index Per Article: 0
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Affiliation(s)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Received: 01/18/2024]
[Revised: 01/24/2024]
[Accepted: 01/29/2024]
[Indexed: 03/05/2024]
Open
Abstract
Collapse
Key Words
Collapse
MESH Headings
Collapse
Grants
Collapse
Affiliation(s)
Peter Mu-Hsin Chang
Department of Oncology, Taipei Veterans General Hospital, Taipei 112, Taiwan; Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
Collapse
Page 1 of 1
1
Loading…
Loading…
Export Articles to File
Export Citation Analysis
Export Citation Analysis
Article Number From
to
A maximum of 600 records can be exported at a time.
Format:
*
Excel
Plain Text
PDF
WORD
Invalid value
Loading…
Click to Download the Exported File
Loading…
Loading…
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Select the Category
Loading…
Loading…
Impact Index Per Article
Calculation for Impact Index Per Article
Times Cited ÷ Number of Years = Impact Index Per Article
TM
Loading…